Assessing the Multimodal Management of Advanced Solitary Fibrous Tumors of the Pleura in a Routine Practice Setting  Olivier Bylicki, Damien Rouvière,

Slides:



Advertisements
Similar presentations
Su K. Metcalfe, MD, MPH, Michael T
Advertisements

CALGB (Alliance): A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib or Pemetrexed Plus Sunitinib in the Second-Line.
Oral Vinorelbine and Cisplatin with Concurrent Radiotherapy After Induction Chemotherapy with Cisplatin and Docetaxel for Patients with Locally Advanced.
Perioperative versus Preoperative Chemotherapy with Surgery in Patients with Resectable Squamous Cell Carcinoma of Esophagus  Yang Zhao, MD, ZhiJun Dai,
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis  Matthew Koshy, MD, Renuka Malik,
Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database  Alex.
Long-Term Results after Treatment for Recurrent Thymoma: A Multicenter Analysis  Alberto Sandri, Giacomo Cusumano, Filippo Lococo, MD, Marco Alifano, Pierluigi.
Mark F. Berry, MD, Thomas A. Sporn, MD, Joseph O. Moore, MD, Thomas A
Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.
Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database  Alex.
Complement and Correction for Meta-Analysis of Patients with Extensive-Stage Small Cell Lung Cancer Managed with Irinotecan/Cisplatin versus Etoposide/Cisplatin.
Multimodality Treatment of Stage III Non-small Cell Lung Cancer: Analysis of a Phase II Trial Using Preoperative Cisplatin and Gemcitabine with Concurrent.
Ellen M. Schultz, MS, Gerard A. Silvestri, MD, MS, Michael K
A New Prognostic Score Supporting Treatment Allocation for Multimodality Therapy for Malignant Pleural Mesothelioma  Isabelle Opitz, MD, Martina Friess,
Electronic Updates for JTO Readers
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer: Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation  Jean-Yves.
Treatment and Prognosis of Isolated Local Relapse after Stereotactic Body Radiotherapy for Clinical Stage I Non-Small-Cell Lung Cancer  Masatsugu Hamaji,
Brian N. Arnold, MD, Daniel C. Thomas, MD, MPH, Joshua E
Lymph Node Ratio May Predict the Benefit of Postoperative Radiotherapy in Non– Small-Cell Lung Cancer  Damien Urban, MBBS, B Med Sc, Jair Bar, MD, PhD,
Frank Detterbeck, MD  Journal of Thoracic Oncology 
Assessment of the ITMIG Statement on the WHO Histological Classification and of the Eighth TNM Staging of Thymic Epithelial Tumors of a Series of 188.
Thymoma—A Clinico-Pathological Long-Term Study with Emphasis on Histology and Adjuvant Radiotherapy Dose  Thomas Harnath, MD, Alexander Marx, MD, Philipp.
Effect of Chemotherapy in Patients With Resected Small-Cell or Large-Cell Neuroendocrine Carcinoma  Nader Abedallaa, MD, Lise Tremblay, MD, Charlotte.
Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non–Small-Cell.
The Influence of the Evolution of First-Line Chemotherapy on Steadily Improving Survival in Advanced Non-Small-Cell Lung Cancer Clinical Trials  Krista.
Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial  Stacey.
Thymoma: A Population-Based Study of the Management and Outcomes for the Province of British Columbia  Caroline Mariano, MD, Diana N. Ionescu, MD, Winson.
Meta-Analysis of First-Line Therapies in Advanced Non–Small-Cell Lung Cancer Harboring EGFR-Activating Mutations  Benjamin Haaland, PhD, Pui San Tan,
Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer  Masahiko Harada,
Jeffrey Bradley, MD, Issam El Naqa, PhD  Journal of Thoracic Oncology 
Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors  Benny Weksler, MD, Anthony Holden, MD, Jennifer.
Perception of Lung Cancer among the General Population and Comparison with Other Cancers  Julien Mazières, MD, PhD, Jean-Louis Pujol, MD, PhD, Nikos Kalampalikis,
Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non–Small-Cell Lung Cancer Using the National Cancer Database 
Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q
Support Your Specialty
Computed Tomography RECIST Assessment of Histopathologic Response and Prediction of Survival in Patients with Resectable Non–Small-Cell Lung Cancer after.
Erratum Journal of Thoracic Oncology
Treatment of Malignant Pleural Mesothelioma with Carboplatin, Liposomized Doxorubicin, and Gemcitabine: A Phase II Study  Gunnar Hillerdal, MD, PhD, Jens.
Mitotic Inhibitors Journal of Thoracic Oncology
PD5-1-7: Time trends in nodal CT volume and nodal motion during radiotherapy for patients with stage III non-small cell lung cancer  Geert Bosmans, Angela.
Mirror Mirror on the Wall, Who Is the Fairest of Them All
Dose-per-Fraction Escalation of Accelerated Hypofractionated Three-Dimensional Conformal Radiotherapy in Locally Advanced Non-small Cell Lung Cancer 
Role of Postoperative Radiotherapy in Nonlocalized Thymoma
Oral Vinorelbine and Cisplatin with Concurrent Radiotherapy After Induction Chemotherapy with Cisplatin and Docetaxel for Patients with Locally Advanced.
Phase II Study of Perioperative Chemotherapy with Cisplatin and Pemetrexed in Non– Small-Cell Lung Cancer  Grace K. Dy, MD, Paul N. Bogner, MD, Wei Tan,
Adjuvant Surgery after Carboplatin and VP16 in Resectable Small Cell Lung Cancer  Giulia Veronesi, MD, Paolo Scanagatta, MD, Francesco Leo, MD, Tommaso.
Immune-Modulating Vaccines in Non-small Cell Lung Cancer
Phase I Study of Lenalidomide in Solid Tumors
Maintenance Therapy and Advanced Non–Small-Cell Lung Cancer: A Skeptic's View  Martin J. Edelman, MD, Thierry Le Chevalier, MD, Jean-Charles Soria, MD,
High Frequency of Radiation Pneumonitis in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Concurrent Radiotherapy and Gemcitabine.
International Thymic Malignancies Interest Group: A Way Forward
Outcome of Multimodality Treatment for 188 Cases of Type B3 Thymoma
Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated.
Combined Evaluation of Postoperative Serum Levels of Carcinoembryonic Antigen Less than or Equal to 2.5 ng/ml and Absence of Vascular Invasion may Predict.
IASLC 6th Latin American Conference on Lung Cancer
Neal S Goldstein, MD  The Annals of Thoracic Surgery 
Tumor Lysis Syndrome in Limited-Stage Small-Cell Lung Cancer
APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28
The Development of an International Registry
Liseth L. van den Berg, MD, Theo J. Klinkenberg, MD, Harry J. M
PARAMOUNT: Descriptive Subgroup Analyses of Final Overall Survival for the Phase III Study of Maintenance Pemetrexed versus Placebo Following Induction.
Jamie E. Chaft, MD, Camelia S. Sima, MD, MS, Michelle S
Induction Therapy For Locally Advanced Thymoma
A Randomized, Phase II Trial of Two Dose Levels of Temsirolimus (CCI-779) in Patients with Extensive-Stage Small-Cell Lung Cancer Who Have Responding.
Randomized Phase II Study of Maintenance Irinotecan Therapy Versus Observation Following Induction Chemotherapy with Irinotecan and Cisplatin in Extensive.
Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the.
A Randomized Phase II Trial Assessing in Advanced Non-small Cell Lung Cancer Patients with Stable Disease after Two Courses of Cisplatin-Gemcitabine an.
Razvan Diaconescu, MD, Chantal Lafond, MD, Renaud Whittom, MD 
Presentation transcript:

Assessing the Multimodal Management of Advanced Solitary Fibrous Tumors of the Pleura in a Routine Practice Setting  Olivier Bylicki, Damien Rouvière, Philippe Cassier, Lara Chalabreysse, Alice Levard, Jean-Michel Maury, Jacques Margery, Jean-Yves Blay, Julien Mazières, Nicolas Girard, MD  Journal of Thoracic Oncology  Volume 10, Issue 2, Pages 309-315 (February 2015) DOI: 10.1097/JTO.0000000000000401 Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 First-intent treatment and recurrences according to the De Perrot stage. S, surgery; C, chemotherapy; R, radiotherapy. Journal of Thoracic Oncology 2015 10, 309-315DOI: (10.1097/JTO.0000000000000401) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 First-intent chemotherapy: intent of the treatment, regimen, and response. Doxo, doxorubine; MAID, mesna, doxorubicine, ifosfamide, and dacarbazine; CDDP–PEM, cisplatine and pemetrexed; PD, progressive disease; SD, stable disease; CR, complete response (indicates the absence of residual tumor after surgery). Journal of Thoracic Oncology 2015 10, 309-315DOI: (10.1097/JTO.0000000000000401) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 3 Relapse-free survival after first-intent surgery, according to the De Perrot stage. Journal of Thoracic Oncology 2015 10, 309-315DOI: (10.1097/JTO.0000000000000401) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 4 Treatment of first recurrence. Post-op CT, postoperative chemotherapy; CT, chemotherapy. Journal of Thoracic Oncology 2015 10, 309-315DOI: (10.1097/JTO.0000000000000401) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions